褪黑素能否改善初次全膝关节置换术后的睡眠?一项随机双盲安慰剂对照试验
该随机双盲安慰剂对照试验纳入138例初次择期全膝关节置换术患者,随机接受每晚5毫克褪黑素或安慰剂共14天,128例完成方案。褪黑素组在术后第2、3天及第1至3天平均睡眠时长有延长趋势但未达统计学显著,术后第4天及以后无差异,两组睡眠障碍评分变化相当。作者认为褪黑素可能延长术后早期睡眠,但获益在术后第3天后减弱,褪黑素安全且可考虑用于术后早期睡眠障碍的患者。
要点
- 褪黑素组术后第2、3天及第1至3天平均睡眠时长有延长趋势,但未达统计学显著。
- 两组术前与术后睡眠障碍评分变化及睡眠障碍增加比例相当。
- 作者认为褪黑素可能延长术后早期睡眠,获益在术后第3天后减弱,褪黑素安全且可考虑用于术后早期睡眠障碍患者。
核心结论
- 褪黑素可能促进全膝关节置换术后早期睡眠时间延长,但这些获益在术后第3天后减弱。
- 大多数患者术后预期会出现睡眠障碍,褪黑素可能具有减轻作用。
- 褪黑素安全,可考虑用于全膝关节置换术后早期出现睡眠障碍的患者。
研究设计与样本
- 研究为随机双盲安慰剂对照试验,前瞻性纳入2021年7月19日至2024年1月4日期间接受初次择期全膝关节置换术的患者。
- 患者随机接受每晚5毫克褪黑素或安慰剂,术后共14天。
- 共138例患者入组,128例成功完成研究方案,每组64例。
主要发现
- 术后第2天睡眠时长:安慰剂组5.0±2.4小时 vs 褪黑素组5.8±2.0小时,P=0.084。
- 术后第3天睡眠时长:安慰剂组5.6±2.2小时 vs 褪黑素组6.3±2.0小时,P=0.075。
- 术后第1至3天平均睡眠时长:安慰剂组4.9±2.0小时 vs 褪黑素组5.6±1.8小时,P=0.073。
- 术后第1天夜间觉醒次数:安慰剂组4.4±3.9次 vs 褪黑素组3.6±2.4次,P=0.197,未达统计学显著。
- 术前与术后患者报告结局测量信息系统睡眠障碍评分增加:安慰剂组4.0±8.4 vs 褪黑素组4.6±8.2,P=0.894;睡眠障碍增加比例褪黑素组65.4% vs 安慰剂组65%。
临床怎么用
- 作者认为褪黑素安全,可考虑用于全膝关节置换术后早期出现睡眠障碍的患者。
局限性
- 褪黑素组睡眠时长延长趋势未达统计学显著(术后第2天P=0.084,术后第3天P=0.075,术后第1至3天平均P=0.073)。
- 术后第1天夜间觉醒次数减少未达统计学显著(P=0.197)。
- 作者结论指出褪黑素的获益在术后第3天后减弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleep impairment following total knee arthroplasty (TKA) is common and may decrease patient satisfaction and recovery. Standardized postoperative recommendations for sleep disturbances have not been established. We aimed to assess whether melatonin use could promote healthy sleep and reduce sleep disturbance in the acute period following TKA. METHODS: Patients undergoing primary, elective TKA between July 19, 2021 and January 4, 2024 were prospectively enrolled and randomized to receive either 5 mg of melatonin nightly or placebo for 14 days postoperatively. Participants recorded their nightly pain on the visual analog scale, the number of hours slept, and the number of night-time awakenings in a sleep diary starting the night of surgery (postoperative day [POD] 0). Sleep disturbance was assessed preoperatively and on POD 14 using the patient-reported outcome measurement information system sleep disturbance form. Epworth Sleepiness Scores were collected on POD 14 to assess sleep quality. RESULTS: Of the 138 patients enrolled, 128 patients successfully completed the study protocol, with 64 patients in each group. Melatonin patients trended toward more hours of sleep on POD 2 (placebo: 5.0 ± 2.4, melatonin: 5.8 ± 2.0, P = .084), POD 3 (placebo: 5.6 ± 2.2, melatonin: 6.3 ± 2.0, P = .075), and averaged over POD 1 to 3 (placebo: 4.9 ± 2.0, melatonin: 5.6 ± 1.8, P = .073), although no differences were observed on POD 4 or after. Fewer night-time awakenings in the melatonin group were observed on POD 1 (placebo: 4.4 ± 3.9, melatonin: 3.6 ± 2.4, P = .197), although this was not statistically significant. Preoperative and postoperative Patient-Reported Outcomes Measurement Information System Sleep Disturbance score increases were comparable for both groups (placebo: 4.0 ± 8.4, melatonin: 4.6 ± 8.2, P = .894). The melatonin (65.4%) and placebo (65%) groups demonstrated similar rates of increased sleep disturbance. CONCLUSIONS: Melatonin may promote longer sleep in the immediate postoperative period after TKA, although these benefits wane after POD 3. Disturbances in sleep should be expected for most patients, although melatonin may have an attenuating effect. Melatonin is safe and can be considered for TKA patients experiencing early sleep disturbances postoperatively.
引用
- Haider MA, Lawrence KW, Christensen T, et al. Does Melatonin Improve Sleep Following Primary Total Knee Arthroplasty? A Randomized, Double-Blind, Placebo-Controlled Trial. J Arthroplasty. 2024. PMID: 38401621. doi:10.1016/j.arth.2024.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。